Purchases and Sales Made in Q4 2022 in Verona Pharma PLC (VRNA)
This table provides information about the institutional ownership of Verona Pharma PLC (VRNA) during Q4 2022. The information is specifically focused on institutions that hold shares of Verona Pharma plc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
BUY
|
- |
780New |
$7.68K - $20.4K
|
780
$58.8K
|
|
Jan 31, 2023
Q4 2022
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
617New |
$6.07K - $16.1K
|
617
$46.5K
|
|
Feb 10, 2023
Q4 2022
|
Core Cap Advisors, LLC
Southfield, MI |
BUY
|
- |
600New |
$5.9K - $15.7K
|
600
$45.3K
|
|
Feb 06, 2023
Q4 2022
|
Daiwa Securities Group Inc.
Tokyo, M0 |
BUY
|
- |
244New |
$2.4K - $6.38K
|
244
$18.4K
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
178+ 32.19% |
$1.75K - $4.65K
|
731
$55.1K
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
100+ 100.0% |
$984 - $2.61K
|
200
$15.1K
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 10, 2023
Q4 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-89- 25.72% |
$876 - $2.33K
|
257
$19.4K
|
|
Aug 14, 2024
Q4 2022
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
SELL
|
- |
-250- 38.46% |
$2.46K - $6.53K
|
400
$30.2K
|
|
Feb 06, 2023
Q4 2022
|
Brinker Capital Investments, LLC
|
SELL
|
- |
-380- 3.08% |
$3.74K - $9.93K
|
11.9K
$901K
|
|
Feb 10, 2023
Q4 2022
|
Sei Investments CO
Oaks, PA |
SELL
|
- |
-390- 2.9% |
$3.84K - $10.2K
|
13.1K
$986K
|
|
Feb 14, 2023
Q4 2022
|
Glenmede Trust CO Na
Philadelphia, PA |
SELL
|
- |
-1.91K- 6.32% |
$18.8K - $49.9K
|
28.3K
$2.14M
|
|
Feb 14, 2023
Q4 2022
|
Hsbc Holdings PLC
London, X0 |
SELL
|
- |
-5K- 33.24% |
$49.2K - $131K
|
10K
$757K
|
|
Feb 03, 2023
Q4 2022
|
D.A. Davidson & Co.
|
SELL
|
- |
-6K- 15.0% |
$59K - $157K
|
34K
$2.56M
|
|
Jan 23, 2023
Q4 2022
|
Moody Aldrich Partners LLC
|
SELL
|
- |
-6.81K- 2.99% |
$67K - $178K
|
221K
$16.7M
|
|
Feb 14, 2023
Q4 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-8.91K- 19.04% |
$87.7K - $233K
|
37.9K
$2.86M
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-10.7K- 25.26% |
$105K - $279K
|
31.7K
$2.39M
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-18.5K- 50.91% |
$182K - $484K
|
17.8K
$1.35M
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-18.5K- 50.91% |
$182K - $484K
|
17.8K
$1.35M
|
|
May 21, 2024
Q4 2022
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-19.6K- 96.95% |
$193K - $512K
|
617
$46.5K
|
|
Feb 14, 2023
Q4 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-23.6K- 54.99% |
$232K - $616K
|
19.3K
$1.46M
|
|
Feb 13, 2023
Q4 2022
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-37.5K- 10.71% |
$369K - $980K
|
312K
$23.6M
|
|
Feb 07, 2025
Q4 2022
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-53.1K- 71.3% |
$523K - $1.39M
|
21.4K
$1.61M
|
|
Feb 14, 2023
Q4 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-60K- 19.04% |
$590K - $1.57M
|
255K
$19.2M
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-61.3K- 96.95% |
$604K - $1.6M
|
1.93K
$146K
|
|
Feb 14, 2023
Q4 2022
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-125K- 33.34% |
$1.23M - $3.27M
|
250K
$18.9M
|
|
Feb 14, 2023
Q4 2022
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-167K- 3.3% |
$1.64M - $4.35M
|
4.88M
$368M
|
|
Feb 14, 2023
Q4 2022
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-189K- 46.78% |
$1.86M - $4.94M
|
215K
$16.2M
|
|
Feb 14, 2023
Q4 2022
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-244K- 25.98% |
$2.4M - $6.37M
|
695K
$52.4M
|
|
Feb 14, 2023
Q4 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-350K- 81.03% |
$3.44M - $9.14M
|
81.9K
$6.18M
|
|
Feb 14, 2023
Q4 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-438K- 97.44% |
$4.31M - $11.4M
|
11.5K
$865K
|
|
Feb 13, 2023
Q4 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-831K- 19.89% |
$8.18M - $21.7M
|
3.35M
$252M
|
|
Feb 14, 2023
Q4 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-1.12M- 19.71% |
$11M - $29.3M
|
4.57M
$345M
|